Latka logo

Ai-biopharma vs Xebra®: Collaborative MSME Biz Suite: Revenue, Funding & Team Size Compared

Ai-biopharma generates $660K in revenue; Xebra®: Collaborative MSME Biz Suite generates $660K. Ai-biopharma and Xebra®: Collaborative MSME Biz Suite are close to the same size by revenue. The table below compares Ai-biopharma and Xebra®: Collaborative MSME Biz Suite on funding, valuation, customers, team size and headquarters — every figure GetLatka has verified for each company.

Ai-biopharma vs Xebra®: Collaborative MSME Biz Suite compared on revenue, funding, valuation, customers and team size
CompanyAi-biopharma logoAi-biopharmaThis companyXebra®: Collaborative MSME Biz Suite logoXebra®: Collaborative MSME Biz Suite
Revenue$660K$660K
Team size66
FoundedNot disclosed2019
HQMontpellier, FranceIndia

Want the full dataset? GetLatka tracks revenue, funding and team history for thousands of SaaS companies, with charts, growth rates and founder interviews.

Ai-biopharma logo

Ai-biopharma at a glance

Ai-biopharma generates $660K in revenue with 6 employees, headquartered in Montpellier, France.

Revenue
$660K
Team size
6

-Artificial Intelligence powered Drug Discovery. -a Biopharma company specialized in medicinal chemistry research of preclinical drug candidates. Ai -biopharma has in-silico solutions of Chemoinformatics, Molecular Modeling, Docking, Data…

Xebra®: Collaborative MSME Biz Suite logo

Xebra®: Collaborative MSME Biz Suite at a glance

Xebra®: Collaborative MSME Biz Suite generates $660K in revenue with 6 employees, headquartered in India.

Revenue
$660K
Team size
6
Founded
2019

Xebra® is unified, collaborative biz suite that offers CRM, Analytics, Invoicing, HRMS, Accounting, Financial & Banking modules. It is a DIPP-certified FinTech registered with Start-up India, Mumbai Fintech and NASSCOM It unlocks hidden…

Other Ai-biopharma alternatives

Ai-biopharma competes with more than the companies on this page. Browse the full alternative lists to compare revenue, funding and team size across the category.

Ai-biopharma vs Xebra®: Collaborative MSME Biz Suite: frequently asked questions

Is Ai-biopharma or Xebra®: Collaborative MSME Biz Suite bigger?

Ai-biopharma is the bigger company by revenue, at $660K against $660K for Xebra®: Collaborative MSME Biz Suite.

How much revenue does Ai-biopharma make?

Ai-biopharma generates $660K in annual revenue with a team of 6.

How much revenue does Xebra®: Collaborative MSME Biz Suite make?

Xebra®: Collaborative MSME Biz Suite generates $660K in annual revenue with a team of 6.